Previous studies have shown that therapeutic inhibition of IDO, CTLA-4, or PD-L1 in mouse glioma models significantly reduces the number of tumor-infiltrating Treg cells and substantially improves long-term survival. Here, CTLA4 is linked to neoplasm.